Shanghai Henlius Biotech Reports the First Patient Dosing of HLX15 (biosimilar, daratumumab) in P-I Clinical Trial for Multiple My...
Shots: The first patient has been dosed in the P-I trial that consists of 2 parts...
Shots: The first patient has been dosed in the P-I trial that consists of 2 parts...
Shots: The company has completed the patient enrolment in the P-III trial (PHOENIX...
Shots: The 1st patient has been dosed in the P-I/II trial evaluating AU-007 at 4 l...
Shots: The first P-III study evaluates ecnoglutide (qw, SC) in ~210 treatment-na&i...
Shots: The first patient has been dosed in the P-III trial (TROPION-Lung07) evalua...
Shots: The P-III study (CARTITUDE-4) that evaluated the efficacy & safety of C...
Incisive News in 3 Shots.